Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb;24(2):195-203.
doi: 10.1111/ggi.14770. Epub 2023 Dec 29.

Drug-related sarcopenia as a secondary sarcopenia

Masafumi Kuzuya  1   2
Affiliations
Review

Drug-related sarcopenia as a secondary sarcopenia

Masafumi Kuzuya. Geriatr Gerontol Int. 2024 Feb.

Abstract

Sarcopenia has a significant impact on falls, physical function, activities of daily living, and quality of life in older adults, and its prevention and treatment are becoming increasingly important as the global population ages. In addition to primary age-related sarcopenia, activity-related sarcopenia, disease-related sarcopenia, and nutrition-related sarcopenia have been proposed as secondary sarcopenia. Polypharmacy and potentially inappropriate medication based on multiple diseases cause health problems in older patients. In some cases, drugs used for therapeutic or preventive purposes act on skeletal muscle as adverse drug reactions and induce sarcopenia. Although sarcopenia caused by these adverse drug reactions may be more common in older patients, in particular those taking many medications, drug-related sarcopenia has not yet received much attention. This review summarizes drugs that may induce sarcopenia and emphasizes the importance of drug-related sarcopenia as a secondary sarcopenia. Geriatr Gerontol Int 2024; 24: 195-203.

Keywords: adverse drug reactions; drug-related sarcopenia; muscle wasting; sarcopenia.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Rosenberg IH. Summary comments. Am J Clin Nutr 1989; 50: 1231–1233.
    1. Cruz‐Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 2010; 39: 412–423. - PMC - PubMed
    1. Janssen L, Allard NAE, Saris CGJ, Keijer J, Hopman MTE, Timmers S. Muscle toxicity of drugs: when drugs turn physiology into pathophysiology. Physiol Rev 2020; 100: 633–672. - PubMed
    1. Kuzuya M. Effect of drugs on nutritional status and drug‐nutrition interactions in older patients. Geriatr Gerontol Int 2023; 23: 465–477. - PubMed
    1. Ruscica M, Ferri N, Banach M, Sirtori CR, Corsini A. Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications. Cardiovasc Res 2023; 118: 3288–3304. - PubMed